Thermo Fisher Scientific
TMO
2,342 hedge funds and large institutions have $231B invested in Thermo Fisher Scientific in 2021 Q4 according to their latest regulatory filings, with 334 funds opening new positions, 849 increasing their positions, 822 reducing their positions, and 82 closing their positions.
307% more first-time investments, than exits
New positions opened: 334 | Existing positions closed: 82
17% more capital invested
Capital invested by funds: $198B → $231B (+$33.1B)
13% more funds holding in top 10
Funds holding in top 10: 215 → 243 (+28)
10% more funds holding
Funds holding: 2,131 → 2,342 (+211)
3% more repeat investments, than reductions
Existing positions increased: 849 | Existing positions reduced: 822
0.03% less ownership
Funds ownership: 87.87% → 87.83% (-0.03%)
35% less call options, than puts
Call options by funds: $1.59B | Put options by funds: $2.44B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$818M |
| 2 |
DZ Bank
Frankfurt Am Main,
Germany
|
+$504M |
| 3 |
Marshall Wace
London,
United Kingdom
|
+$400M |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
+$334M |
| 5 |
State Street
Boston,
Massachusetts
|
+$331M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS AM
Chicago,
Illinois
|
-$473M |
| 2 |
VAM
Veritas Asset Management
London,
United Kingdom
|
-$449M |
| 3 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$323M |
| 4 |
GIM
Generation Investment Management
London,
United Kingdom
|
-$300M |
| 5 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$285M |
TMO Hedge Fund Activity: Q4 2021 in Review
2,342 of the 6,519 institutional investors tracked by Wall St. Rank reported a position in Thermo Fisher Scientific (TMO) for Q4 2021, worth a combined $231B — up 17% from $198B a quarter earlier.
Buyers outnumbered sellers: 334 funds opened new TMO positions and 82 closed out — a net gain of 252 holders — while 849 added to existing stakes and 822 trimmed.
The largest buyer was BlackRock, adding an estimated $818M. The largest seller was UBS AM, cutting an estimated $473M.
- 2,342 institutional investors held Thermo Fisher Scientific (TMO) as of Q4 2021, up from 2,131 in Q3 2021.
- Funds reported $231B of Thermo Fisher Scientific stock for Q4 2021, up 17% quarter-over-quarter.
- 334 funds opened new Thermo Fisher Scientific positions in Q4 2021 and 82 closed out, a net change of +252 holders.
- The largest Thermo Fisher Scientific buyer in Q4 2021 was BlackRock, an estimated $818M added.
- The largest Thermo Fisher Scientific seller in Q4 2021 was UBS AM, an estimated $473M sold.
Based on aggregated 13F filings for Q4 2021.